
María José Rabanaque: “I consider it a social task to provide useful information to improve the health of the population and to help in decision-making in planning services”
24 July 2024Grant for Research into Genetic Intellectual Disabilities 2024
24 July 2024Through this call, we seek to support projects that help identify and address data gaps and advance the understanding of the use of etrasimod and tofacitinib in the Ulcerative Colitis (UC) treatment landscape. This may include:
- Exploration of optimal ultrasonographic markers.
- Evaluation of the extra-intestinal manifestations of Ulcerative Colitis.
- Evaluation in specific subgroups of special interest.
- Evaluation of an advanced sequencing therapy strategy.
Requirements
Only groups associated with an institution are eligible to receive funding, independent individuals or groups will be rejected.
Applicants must:
- Residing in an eligible country (Germany, Austria, Finland, Denmark, Norway, Netherlands, Italy, Spain, Switzerland, Belgium, Czech Republic, Canada, Australia or the United Kingdom).
- Have an IP that:
- Have a current contract with the requesting entity.
- Hold a doctor's or medical specialist degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with MS/PhD), or a degree in pharmacy, physical therapy, or social work.
If the project involves more than one center or department belonging to one or more institutions, each of the parties must have a relevant role in the project.
Deadline: August 5, 2024.